Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

Routine Evaluation of People Living With Cancer

Sponsor: University of Edinburgh

NCT ID: NCT04406662

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Not specified by the sponsor
How long the study runs
Study runs about 109 months (dates as stated)
About the drug or intervention
Not specified by the sponsor
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
18 Years and over
Who
All
Number of participants
600
Started
2020-07-15
Last checked
2026-07

Plain English Summary

What is this study?

  • • Testing a new treatment for cachexia; cancer
  • • Clinical study - 600 participants
  • • People with incurable cancer often have complex individual needs, however there are several common themes encountered when considering this group

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with cachexia; cancer

Where?

  • • Edinburgh - St Columba's Hospice

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

People with incurable cancer often have complex individual needs, however there are several common themes encountered when considering this group. As cancer progresses there are series of interactions between the tumour and the patient, producing both local and systemic effects. This altered state of illness can have multiple ill effects including weight loss, fatigue, increased symptom burden and reduction in physical function which all contribute to a reduced quality of life. These areas are often studied in isolation, giving an incomplete picture. A detailed, holistic characterisation of this group of people does not exist. A robust characterisation of people with incurable cancer will allow identification and prioritisation of future research and has the potential to inform new therapeutics and provide justification for treatments. This study aims to collect information about symptoms and quality of life, weight loss and body composition, physical activity and the body's immune response to cancer. Participants with incurable cancer will be recruited to the study from oncology and palliative medicine services in the UK. Participants will answer questionnaires about quality of life and symptoms, have bloods taken for inflammatory marker and cytokine analysis and have their body composition measured by a variety of methods.

Cachexia; CancerAdvanced CancerQuality of Life

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Patients with incurable cancer (that has spread cancer (Clinical, histological, cytological or radiological evidence) or...
  • ✓Aged 18-years and over
  • ✓Written agreement to take part

Who cannot take part

  • ✗Any concomitant medical or psychiatric problems which, in the opinion of the investigator, would increase the risk...
  • ✗Participants will not be able to take part in bio-impedance analysis if they have a pacemaker or implantable heart...
See the full criteria
Inclusion Criteria: * Patients with incurable cancer (metastatic cancer (Clinical, histological, cytological or radiological evidence) or receiving anti-cancer therapy with palliative intent). * Aged 18-years and over * Written informed consent Exclusion Criteria: * Any concomitant medical or psychiatric problems which, in the opinion of the investigator, would increase the risk of complication for the participant and/or investigator. * Participants will not be able to take part in bio-impedance analysis if they have a pacemaker or implantable cardiac defibrillator.

Where Is This Study? (1 UK site)

St Columba's Hospice

Edinburgh EH53RW, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

Barry JA Laird, MBCHB MD

Sponsor contact

CONTACT

01316518611 barry.laird@ed.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2026-07